Lisette van Dam

Chapter 3 54 29. Barco S, Mahmoudpour SH, Valerio L, et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med . 2020;8(3):277-287. 30. Barco S, Valerio L, Ageno W, et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med . 2020. 31. van der Wall SJ, van der Pol LM, Ende-Verhaar YM, et al. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review. Eur Respir Rev . 2018;27(150). 32. Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med . 2007;147(11):766-774. 33. Mühlbacher AC, Sadler A. The Probabilistic Efficiency Frontier: A Framework for Cost- Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options. Value Health . 2017;20(2):266-272. 34. Zorginstituut Nederland. Cost-effectiveness in practice. [Available from: https:// english.zorginstituutnederland.nl/publications/reports/2015/06/16/cost-effectiveness- in-practice]. (January, 22, 2021) 35. Opendata. Central Bureau voor Statistiek (CBS), StatLine. Gezonde levensverwaching; vanaf 1981. [Available from: https://opendata.cbs.nl/statline/#/CBS/nl/ dataset/71950ned/table?ts=1600339908339]. (January, 22, 2021) 36. M MV, K MV, S MAAE, de Wit GA, Prenger R, E AS. Dutch Tariff for the Five-Level Version of EQ-5D. Value Health . 2016;19(4):343-352. 37. Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev . 2014;28(6):221-226. 38. Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J . 2017;49(2). 39. Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood . 2018;131(20):2215-2222. 40. Kanters TA, Bouwmans CAM, van der Linden N, Tan SS, Hakkaart-van Roijen L. Update of the Dutch manual for costing studies in health care. PLoS One . 2017;12(11):e0187477. 41. Simonneau G, D’Armini AM, Ghofrani HA, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J . 2015;45(5):1293-1302. 42. Fukui S, Ogo T, Goto Y, et al. Exercise intolerance and ventilatory inefficiency improve early after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol . 2015;180:66-68.